Robin C. Kramer

Robin C. Kramer joined the board of directors of Armata Pharmaceuticals in December 2020, and in March 2023 was appointed to chair the Company’s board of directors. Ms. Kramer also chairs Armata’s Audit Committee.

Robin Kramer is Executive Vice President and Chief Financial Officer at Biogen and has served on Biogen’s Executive Committee since March 2025. Ms. Kramer joined Biogen in 2018 as Vice President, Chief Accounting Officer and most recently served as Senior Vice President, Chief Accounting Officer. Prior to joining Biogen, Ms. Kramer served as the Senior Vice President and Chief Accounting Officer at Hertz Global Holdings from 2014 to 2018. Prior to that, she was an audit partner at Deloitte & Touche from 2007 to 2014, including serving in Deloitte’s National Office Accounting Standards and Communications Group for several years. Earlier in her career, Ms. Kramer served as Chief Accounting Officer of Fisher Scientific International and as Director, External Reporting, Accounting and Control for the Gillette Company. Ms. Kramer also held partner positions in the public accounting firms of Ernst & Young LLP and Arthur Andersen LLP.

Ms. Kramer is a member of the Massachusetts Society of CPAs and the American Institute of CPAs. Previously, Ms. Kramer served as a Board Member for Samsung Bioepis, the Center for Women and Enterprise, the Massachusetts State Board of Accountancy, and Probus Insurance Company Europe DAC.

Ms. Kramer holds a Bachelor of Science in Business Administration in Accounting from Salem State University and is a licensed Certified Public Accountant in Massachusetts.